Tag Archives: Pharmaceutical Research and Manufacturers of America

Trump’s Exec Order on drug pricing proves he’s like the leopard; he can’t change his spots

A draft of President Donald Trump’s executive order on drug prices lists several proposals to lessen regulatory hurdles for the pharmaceutical industry, reports The New York Times. Here are four things… Read more »

PTC Therapeutics catches falling knife with Emflaza buy; or did it?

Every now and again I’ll read about what seems on its face a boneheaded business deal between two Pharma companies and try to blow the lid off some super-stealthy, strategic,… Read more »

Trump backs negotiating drug prices under Medicare; unless he doesn’t

The News: President Donald Trump supports Medicare drug price negotiations, his spokesman said last week, remarks that sent pharmaceutical stocks swinging again as investors tried to assess whether drugmakers will… Read more »

Trump and pharma execs make nice; what, Sen. Sanders too?

The News: Last week (January 30, 2017), President Trump promised some of the nation’s top drug-company executives in a meeting at the White House that he would shrink Food and… Read more »

Trump scorns Pharma, calls for drug pricebidding; stocks swoon on latest pivot, but does the POTUS-elect mean it?

President-elect Donald Trump on Wednesday (January 11, 2017) pledged to change the way the federal government purchases prescription drugs, a striking, largely unforseen warning to the drug industry that he… Read more »